πŸ‡ΊπŸ‡Έ FDA
Patent

US 10677801

Diagnosis and treatment of breast cancer

granted A61KA61K31/4196A61K31/5685

Quick answer

US patent 10677801 (Diagnosis and treatment of breast cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/4196, A61K31/5685